within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10A_InsulinsAndAnalogues.A10AE02_InsulinBeef;

model InsulinBeef
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 3.333333333333333e-07,
    adminDuration = 600,
    adminMass = 10 / 1000000,
    adminCount = 1,
    Vd = 0.00014000000000000001,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.0004,
    k12 = 5.833333333333334e-07,
    k21 = 5.833333333333334e-07);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>InsulinBeef</td></tr><tr><td>ATC code:</td><td>A10AE02</td></tr><td>route:</td><td>subcutaneous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>10</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.14</td><td>L</td></tr>
    <tr><td>clearance:</td><td>1.2</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Beef insulin is a polypeptide hormone derived from the pancreas of cattle. It is used as a replacement therapy for diabetes mellitus to control hyperglycemia when endogenous insulin production is insufficient. Beef insulin was used historically in human medicine but has largely been replaced by human and analog insulins due to lower immunogenicity and improved safety. It is not commonly used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameter estimates are summarized for healthy and diabetic adult humans following subcutaneous administration of beef insulin.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.A.A10AE02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end InsulinBeef;
